Concepedia

Yinci Zhang

YZ

20

Publications

597

Citations

17

H-Index

2017

Active since

Affiliations

Anhui University of Science and Technology(Current)

Second People’s Hospital of Huai’an

Xuzhou Medical College

First Affiliated Hospital of Bengbu Medical College

Jinan University

Yinci Zhang is an author at Anhui University of Science and Technology specializing in medicine, cell biology, and cancer biology.

ORCID

Top concepts

Publications per year

2017–2022

20

Publications

20

Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma

Xiaolong Tang, Longzhou Chen, Amin Li et al. · Drug Delivery · 2018 · 62 citations · Full text

, , +20

Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma

Huaiyong Gan, Longzhou Chen, Xuemei Sui et al. · Materials Science and Engineering C · 2018 · 53 citations

, , +10

PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.

Yinci Zhang, Chunmei Xie, Amin Li et al. · PubMed · 2019 · 44 citations · Full text

, , +17

Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals

Yinci Zhang, Jiaojiao Liang, Niandie Cao et al. · Cell Death Discovery · 2022 · 44 citations · Full text

Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3

Weiya Cao, Yinci Zhang, Amin Li et al. · Toxicology Mechanisms and Methods · 2021 · 40 citations

Rows per page

1–5 of 20